Efient is a medicine taken together with aspirin to prevent atherothrombotic events (problems caused by blood clots and hardening of the arteries) in adults with acute coronary syndrome who are undergoing percutaneous coronary intervention. Acute coronary syndrome is a group of conditions in which blood supply in the vessels supplying the heart is interrupted so heart tissue cannot work properly or dies. It includes unstable angina (a severe type of chest pain) and heart attack. Percutaneous coronary intervention is a procedure used to unblock the blood vessels supplying the heart. Efient contains the active substance prasugrel.
Therapeutic Indication
Efient, co\-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome (i.e. unstable angina, non\-ST\-segment\-elevation myocardial infarction \[UA / NSTEMI\] or ST\-segment\-elevation myocardial infarction \[STEMI\]) undergoing primary or delayed percutaneous coronary intervention (PCI).
Therapeutic Area (MeSH)
ATC Code
B01AC22
ATC Item
N/A
Pharmacotherapeutic Group
Antithrombotic agents
Active Substance (Summary)
INN / Common Names
EMA Name
Efient
Medicine Name
Efient
Aliases
N/ANo risk management plan link.
